Los Altos, Calif.-based Evena Medical Inc. launched the 3.0 version of its Eyes-On Glasses in November. The device does not require regulatory approval, but it is listed with the U.S. Food and Drug Administration.

Eyes-On Glasses 3.0 offer clinicians the first point-of-care wearable system for deep tissue vascular imaging. Featuring a patent-pending design incorporating multispectral light imaging and wireless connectivity, Evena’s Eyes-On system was, according to the company, the first device to deliver clear, anatomically accurate, real-time vascular imaging in a wearable, easy-to-use, hands-free and cart-free system. The system offers medical professionals the first complete vascular imaging platform available today, offering large, clinically useful images for adult primary care, pediatrics, emergency medical care and other medical specialties. Augmented reality capabilities are also available on the new platform, enabling digital overlays during medical training.

“The Eyes-On 3.0 system offers medical professionals the first complete vascular imaging platform available today, offering large, clinically useful images for adult primary care, pediatrics, emergency medical care and other medical specialties,” said Frank Ball, president and CEO of Evena Medical. “With our DeepVu ultrasound, clinicians can now visualize veins deep beneath the skin with superior, real-time imaging in front of their eyes with simple, hands-free operation.”

The Eyes-On platform uses the custom camera by Japan-based Xacti Corporation, maker of digital still/video camera technologies. Eyes-On Glasses 3.0 uses Evena and Xacti’s proprietary technologies to attain super high-quality images and Augmented Vision/Augmented Reality [AV/AR] without the image latency problems encountered on most smart glasses during real-world imaging procedures. In addition to its unique “situational awareness” capabilities, the Eyes-On platform is one of the first healthcare applications of smart glasses commercially available on a global scale—developed for clinicians, by clinicians.

“Venipuncture is the most common invasive medical procedure, yet studies have shown that up to 40 percent of IV starts require multiple attempts to locate and access a vein, which not only wastes valuable nursing time but also delays therapy and causes patient discomfort and dissatisfaction,” added Ball. “With Evena’s Eyes-On Glasses, nurses can quickly and easily locate and access the best veins for each patient – even in challenging clinical environments such as pediatric or neonatal units.”

“It’s extremely gratifying that one of the first healthcare solution concepts features Xacti technology as one that improves both patient comfort and nursing efficiency,” said Takeo Isaji, chairman of Xacti. “We are proud of what the Evena team has accomplished and look forward to working with them well into the future.”